These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2838780)

  • 1. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
    Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
    Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
    Ibson JM; Waters JJ; Twentyman PR; Bleehen NM; Rabbitts PH
    J Cell Biochem; 1987 Apr; 33(4):267-88. PubMed ID: 3034934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
    Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
    Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
    Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
    Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE; Thorgeirsson SS
    Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
    Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
    Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice.
    Gazzeri S; Brambilla E; Jacrot M; Chauvin C; Benabid AL; Brambilla C
    Cancer Res; 1991 May; 51(10):2566-71. PubMed ID: 1850659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
    Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
    Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
    Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
    Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
    Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
    Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ
    Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.